GW501516
| Price | $10 |
| Package | 1KG |
| Min. Order: | 1KG |
| Supply Ability: | Ex 20 tons |
| Update Time: | 2022-10-25 |
Product Details
| Product Name: GW501516 | CAS No.: 317318-70-0 |
| EC-No.: 206-141-6 | Min. Order: 1KG |
| Purity: 99% | Supply Ability: Ex 20 tons |
| Release date: 2022/10/25 |
| Name | 2-[2-methyl-4-[[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]methylsulfanyl]phenoxy]acetic acid |
|---|---|
| Synonym | More Synonyms |
| Description | GW 501516 is a PPARδ agonist with an EC50 of 1.1 nM. |
|---|---|
| Related Catalog | Signaling Pathways >> Autophagy >> Autophagy Signaling Pathways >> Cell Cycle/DNA Damage >> PPAR Research Areas >> Metabolic Disease |
| Target | PPARδ:1.1 nM (EC50) |
| In Vitro | GW 501516 is shown to be the most potent and selective PPARα agonists known with an EC50 of 1.1 nM against PPARα and 1000-fold selectivity over the other human subtypes, PPARα and-γ[1]. GW 501516 exerts anti-inflammatory effects in mouse cultured proximal tubular (mProx) cells. GW 501516 inhibits palmitate- and TNFα-induced increases in MCP-1 mRNA expression in a dose-dependent manner[3]. |
| In Vivo | GW 501516 causes impaired bone formation, leading to decreased BMD and deterioration of bone properties in OVX rats[2]. GW 501516 attenuates interstitial inflammation and proximal tubular cell damage in a protein-overload mouse nephropathy model[3]. GW 501516 treatment enhances running endurance and the proportion of succinate dehydrogenase (SDH)-positive muscle fibres in both trained and untrained mice[4]. |
| Solvent | In Vitro: 10 mM in DMSO In Vivo: 1.GW 501516 is prepared in vehicle control (saline containing 0.5% DMSO)[5]. |
| Solubility | 1 mM2.2051 mL11.0254 mL22.0507 mL5 mM0.4410 mL2.2051 mL4.4101 mL10 mM0.2205 mL1.1025 mL2.2051 mL |
| Cell Assay | GW 501516 is dissolved in DMSO. Cells are starved by incubation in 0.2% FCS DMEM for 9 h, then pre-incubated with GW 501516, at a final concentration of 2.5 and 5 μM, or 0.05% DMSO as control for 3 hours, followed by stimulation with 150 μM palmitate bound to 8.0% BSA for 12 h[3]. |
| Animal Admin | Rats: Female Sprague Dawley rats, 12 weeks of age, are allocated to a sham-operated group and 3 OVX groups; high-dose GW 501516 (OVX-GW5), low-dose GW 501516 (OVX-GW1), and a control group (OVX-CTR), respectively. Animals receive GW 501516 or vehicle (methylcellulose) daily for 4 months by gavage. Bone mineral density (BMD) is assessed by dual x-ray absorptiometry at the femur, spine, and whole body[2]. Mice: Mice are randomly allocated to different groups and receive therapeutic diet and treatment. The GW 501516-containing rodent diet is made by evenly adding GW 501516 to the control diet to a final concentration of 0.04% w/w. In the control diet, 10% of the total calories are from fat (5.5% from soybean oil and 4.5% from lard)[3]. |
| Storage | Powder-20°C3 years 4°C2 yearsIn solvent-80°C6 months -20°C1 month |
| Shipping | Room temperature in continental US; may vary elsewhere |
| SMILES | OC(COC1=CC=C(C=C1C)SCC2=C(N=C(S2)C3=CC=C(C=C3)C(F)(F)F)C)=O |
| References | [1]. Wei ZL, et al. A short and efficient synthesis of the pharmacological research tool GW501516 for the peroxisome proliferator-activated receptor delta. J Org Chem. 2003 Nov 14;68(23):9116-8. [2]. Mosti MP, et al. Effects of the peroxisome proliferator-activated receptor (PPAR)-δ agonist GW 501516 on bone and muscle in ovariectomized rats. Endocrinology. 2014 Jun;155(6):2178-89. [3]. Yang X, et al. GW 501516, a PPARδ agonist, ameliorates tubulointerstitial inflammation in proteinuric kidney disease via inhibition of TAK1-NFκB pathway in mice. PLoS One. 2011;6(9):e25271. [4]. Chen W, et al. A metabolomic study of the PPARδ agonist GW 501516 for enhancing running endurance in Kunming mice. Sci Rep. 2015 May 6;5:9884. [5]. Ji Y, et al. PPARβ/δ Agonist GW501516 Inhibits Tumorigenicity of Undifferentiated Nasopharyngeal Carcinoma in C666-1 Cells by Promoting Apoptosis. Front Pharmacol. 2018 Jun 28;9:648. |
| Related Molecules | GW9662 | Tretinoin | Elafibranor | Troglitazone | T0070907 | Pemafibrate | CDDO-Im | Wy-14643 | GW0742 | GW1929 | FH535 | Icariin | Daidzein | Fisetin | GSK0660 |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 584.5±60.0 °C at 760 mmHg |
| Melting Point | 134-136°C |
| Molecular Formula | C21H18F3NO3S2 |
| Molecular Weight | 453.498 |
| Flash Point | 307.3±32.9 °C |
| Exact Mass | 453.068024 |
| PSA | 112.96000 |
| LogP | 6.29 |
| Vapour Pressure | 0.0±1.7 mmHg at 25°C |
| Index of Refraction | 1.619 |
| Storage condition | Refrigerator |
| Stability | Light Sensitive |
Company Profile Introduction
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $0.00/1Box |
VIP1Y
|
American HealthyMorph LLC
|
2024-12-18 | |
| $0.00/1Bottle |
VIP1Y
|
Shandong Huizhihan Supply Chain Co., Ltd
|
2024-11-05 | |
| $24.00/1box |
VIP1Y
|
Shanghai Getian Industrial Co., LTD
|
2024-06-04 | |
| $30.00/1g |
VIP1Y
|
hebei hongtan Biotechnology Co., Ltd
|
2024-05-11 | |
| $0.00/1G |
VIP1Y
|
CONTIDE BIOTECH CO.,LTD
|
2024-04-12 | |
| $10.00/1kg |
Wuhan Boyuan Import & Export Co., LTD
|
2024-03-25 | ||
| $10.00/1kg |
VIP1Y
|
Wuhan Xinhao Biotechnology Co., Ltd
|
2024-02-23 | |
| $30.00/1bottle |
VIP1Y
|
Sigma Audley
|
2024-01-23 | |
| $40.00/1Box |
zhuzhou dingcheng meihei comestic co.,ltd
|
2023-12-07 | ||
| $10.00/1mg |
Nantong Guangyuan Chemicl Co,Ltd
|
2023-10-31 |
China- Since: 2022-02-24
- Address: 3-1-1005, Federal Business Plaza, 166 Yuhua West Road, Qiaoxi District, Shijiazhuang City, Hebei Pro
INQUIRY
+86-19831998802
106@hebeianda.cn